Welcome to Impact Factor, your weekly dose of commentary on a new medical study, I’m
Dr. F. Perry Wilson of the Yale School of Medicine.
I have a bit of a love-hate relationship with Vitamin D.
A brief search of my blog has shown me questioning the link between Vitamin D and multiple sclerosis,
kidney disease, schizophrenia, falls, and childhood educational attainment.
So it’s no surprise, in the COVID-era, that Vitamin D comes up again.
I was intrigued when Dr. Anthony Fauci, a sober and responsible voice if ever there
was one during this pandemic reported his personal use of Vitamin D. Vitamin D was also
part of the presidential cocktail that Trump received during his stay at Walter Reed.
I decided to dig into the data here, but before we do I want to tell you why I am inherently
skeptical of Vitamin D studies.
Two main issues: 1) Low vitamin D levels have been linked to
so many things.
Like, Vitamin C deficiency gets scurvy – fine, but low Vitamin D has been linked to everything
from Alzheimer’s to Whooping Cough.
It’s either the most important Vitamin in the world, or it’s a stand-in for some other
important thing.
The second reason I’m a bit of a vitamin D skeptic is because when we’ve tested all
these intriguing links via randomized trials, giving some people Vitamin D and some placebo,
they almost always show no effect.
I feel a bit like Charlie Brown with the football here.
Vitamin D has burned us before.
A couple of examples.
Multiple observational studies found that people with low levels of Vitamin D were more
likely to develop cancer and cardiovascular disease.
These were good studies, adjusting for appropriate confounders, the whole deal.
Then we got a 26,000 patient randomized clinical trial.
No effect on either outcome.
Observational studies suggested that low vitamin D levels were linked to the development of
diabetes.
Then we got a trial of 2400 patients with pre-diabetes.
Vitamin D supplementation had no effect.
Observational studies have found that low vitamin D levels are linked to falls.
The randomized trial found no such effect.
(Exercise did prevent falls though).
Does Vitamin D save lives in general?
Not really.
The Women’s Health Initiative Trial randomized 36,000 post-menopausal women to vitamin D
versus placebo and saw no survival benefit.
Look, I’m not saying Vitamin D doesn’t have it’s uses, or that it may have some
limited benefit.
Randomized trials are rarely as dramatic as observational data promises.
But I can’t think of another exposure which has SUCH a wide disconnect between observational
and randomized data.
Why is that?
Because your Vitamin D level is a marker of the type of life you live, and it’s really,
really hard to adjust for that.
Sure, you can ask people how much sun and exercise they get, how varied their diet is,
how much money they make – but these are pretty blunt tools.
OK keeping all of that in mind, what do we know about Vitamin D in Covid?
Just this week we got this study out of Spain that found that, of 216 hospitalized COVID-19
patients, 80% were vitamin D deficient.
Only 40% of controls were deficient.
Of course, the controls weren’t hospitalized.
Or sick actually.
But ok better study.
Back in September which, as of this recording, was like 10 years ago, we got this study out
of Chicago showing that, of 489 patients with prior Vitamin-D testing, those who were Vitamin
D deficient had a 1.77 times higher risk of contracting COVID-19.
This study in PLOS One found, among 235 hospitalized patients, those with Vitamin D levels less
than 30 had a 20% death rate compared to 9.7% in those with higher levels.
I should point out that this article was flagged with an “expression of concern” for some
data weirdness.
Ok so we have multiple observational studies, and Anthony Fauci for crying out loud, saying
we should consider Vitamin D. And why not, really?
It’s cheap.
It’s got a pretty benign side effect profile (though the nephrologist in me worries about
kidney stones).
But when it comes to COVID, multiple factors associated with low Vitamin D levels are also
associated with COVID-19 infection and severity: older age, BMI, Black race, poverty, comorbidities.
It’s just really hard to appropriately account for all of this stuff statistically.
So – I’m gun shy on Vitamin D. I’d love a randomized trial.
Right now we have one, two if you squint.
The one randomized trial is this one, out of Spain.
A small study, 76 patients hospitalized with COVID-19 were randomized in a 2:1 Ratio to
Vitamin D + Azithromycin + Hydroxychloroquine (don’t get me started) versus Azithromycin
and Hydroxychloroquine alone.
Of the 50 people in the Vitamin D group, just 1 went to the ICU.
Compare that to 13 of the 26 in the non-Vitamin D group.
There were zero deaths in the vitamin D group and 2 in the non-Vitamin D group.
I should note that the non-D group here was a bit higher risk at baseline, with more individuals
with diabetes and hypertension.
But honestly, it’s the effect size that surprises me here.
I mean, reducing the risk of ICU admission from 50% to 2%?
That’s just a staggering amount.
So we’re in the space of – is this a miracle drug or is there a problem with the study
we don’t know about.
And miracles are in short supply these days.
Just to throw some cold water on that study, we have this one – still in pre-print, which
used mendelian randomization to look at whether Vitamin D might have a causal link with COVID
severity in over 400,000 individuals.
In this study design, you compare people who are genetically predisposed to lower Vitamin
D levels to those who are not.
That takes lifestyle stuff out of the equation.
Interestingly, people genetically destined to have low vitamin D levels were less likely
to be hospitalized with COVID-19 or to develop severe disease.
Not peer-reviewed yet, grain of salt, etc.
Bottom line?
We know that people with low Vitamin D are at higher risk of bad outcomes in COVID-19.
We still don’t know if Vitamin D supplementation will change that risk.
There is some promise here, but the lifestyle vitamin has burned us before, so proceed with
400 international units of caution.